News and Announcements
Surf Lakes Completes $500k Capital Raise
- Published April 17, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Surf Lakes Limited has invented a revolutionary, proprietary method of produce high quality surfing waves in a controlled lake environment. The Surf Lakes™ technology will be capable of producing a variety of waves that closely mimic natural ocean waves. Furthermore, because of the way Surf Lakes works, not only will it have the lowest energy cost per wave compared to other technologies, but be capable of producing up to 2,400 surfable waves per hour. This is over 20 times more than any current or proposed wave technology around the world.
The company have built several large prototypes and will soon commence construction of a full scale lake in 2017.
Brisbane based Surf Lakes, who is building Australia’s first artificial surf park, recently completed their latest capital raise. They successfully raised $500k at $0.90c per share. As they move into the construction phase for the full scale surf park, located in QLD, they have launched their latest capital raising round.
Wayne Dart appointed as Media Director
Surf Lakes has appointed Wayne Dart as Media Director. Wayne has over 20 years’ experience in the Surfing industry, and has worked across all aspects of the surfing media. In 2005 he was the Media Director for ASP (now WSL). Prior to that he was the manager of Tracks magazine and numerous other action sports titles.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
